{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:15:11Z","timestamp":1785453311574,"version":"3.56.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.juro.2011.09.052","type":"journal-article","created":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T09:27:36Z","timestamp":1321608456000},"page":"178-184","source":"Crossref","is-referenced-by-count":27,"title":["Cost-Effectiveness of Percutaneous Tibial Nerve Stimulation Versus Extended Release Tolterodine for Overactive Bladder"],"prefix":"10.1097","volume":"187","author":[{"given":"Heidi W.","family":"Chen","sequence":"first","affiliation":[{"name":"Section of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Bercik","sequence":"additional","affiliation":[{"name":"Section of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika F.","family":"Werner","sequence":"additional","affiliation":[{"name":"Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Thung","sequence":"additional","affiliation":[{"name":"Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2011.09.052_bib1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0090-4295(03)00009-8","article-title":"Estimated economic costs of overactive bladder in the United States","volume":"61","author":"Hu","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.juro.2011.09.052_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.18553\/jmcp.2008.14.3.291","article-title":"Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan","volume":"14","author":"D'Souza","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.juro.2011.09.052_bib3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0022-5347(05)65863-6","article-title":"Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction","volume":"166","author":"van Balken","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.juro.2009.05.045","article-title":"Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the Overactive Bladder Innovative Therapy trial","volume":"182","author":"Peters","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.juro.2009.08.160","article-title":"Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder","volume":"183","author":"MacDiarmid","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0022-5347(05)66469-5","article-title":"Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study","volume":"165","author":"Govier","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0149-2918(02)85137-2","article-title":"A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: the speed of onset of therapeutic assessment trial (STAT)","volume":"24","author":"Siami","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.juro.2011.09.052_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1442-2042.2005.01066.x","article-title":"Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder in Japanese patients","volume":"12","author":"Takei","year":"2005","journal-title":"Int J Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eururo.2003.08.012","article-title":"Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms","volume":"45","author":"Congregado","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003781.pub2","article-title":"Anticholinergic drugs versus placebo for overactive bladder syndrome in adults","volume":"4","author":"Nabi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.juro.2011.09.052_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0302-2838(02)00177-X","article-title":"Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder","volume":"41","author":"Kreder","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/AOG.0b013e31818e8aa4","article-title":"Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms","volume":"112","author":"Gopal","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.juro.2011.09.052_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2005.10.019","article-title":"Prognostic factors for successful percutaneous tibial nerve stimulation","volume":"49","author":"van Balken","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/nau.10036","article-title":"Posterior tibial nerve stimulation in the treatment of urge incontinence","volume":"22","author":"Vandoninck","year":"2003","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2011.09.052_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1464-410X.2006.06055.x","article-title":"Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary?","volume":"97","author":"van der Pal","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2011.09.052_bib17","series-title":"National wholesale price","year":"2010"},{"key":"10.1016\/j.juro.2011.09.052_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/AOG.0b013e31816a1e12","article-title":"High costs of urinary incontinence among women electing surgery to treat stress incontinence","volume":"111","author":"Subak","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.juro.2011.09.052_bib19","first-page":"S151","article-title":"Quality of life for different overactive bladder severities and treatments","volume":"16","author":"Wu","year":"2010","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.juro.2011.09.052_bib20","first-page":"119","article-title":"Posterior tibial nerve stimulation: is the once-a-week protocol the best option?","volume":"57","author":"Finazzi Agro","year":"2005","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.juro.2011.09.052_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1464-410X.2009.09086.x","article-title":"Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial","volume":"105","author":"Herschorn","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2011.09.052_bib22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0090-4295(00)00727-5","article-title":"Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study","volume":"56","author":"Klingler","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.juro.2011.09.052_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0029-7844(03)00623-9","article-title":"Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine","volume":"102","author":"Freeman","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.juro.2011.09.052_bib24","first-page":"S150","article-title":"Treatment of overactive bladder: a model comparing extended-release formulations of tolterodine and oxybutynin","volume":"11","author":"Perfetto","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.juro.2011.09.052_bib25","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.juro.2009.01.037","article-title":"Cost-effectiveness of botulinum toxin A versus anticholinergic medications for idiopathic urge incontinence","volume":"181","author":"Wu","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib26","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.juro.2010.06.113","article-title":"Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial","volume":"184","author":"Finazzi-Agro","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/0272989X05282640","article-title":"Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation","volume":"25","author":"King","year":"2005","journal-title":"Med Decis Making"},{"key":"10.1016\/j.juro.2011.09.052_bib28","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.juro.2009.12.036","article-title":"Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial","volume":"183","author":"Peters","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1464-410X.1997.00420.x","article-title":"Willingness to pay for reduced incontinence symptoms","volume":"80","author":"Johannesson","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2011.09.052_bib30","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.AOG.0000206213.48334.09","article-title":"The \u201ccosts\u201d of urinary incontinence for women","volume":"107","author":"Subak","year":"2006","journal-title":"Obstet Gynecol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711049974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711049974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2011.09.052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T22:20:45Z","timestamp":1651184445000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2011.09.052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1016\/j.juro.2011.09.052"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2011.09.052","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14264070.15777192","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}